Claudia Kistler

Claudia obtained her PhD in cellular biology at Max-Planck-Institute for Medical Research (Heidelberg, Germany) and subsequently worked at the German Cancer Research Center where she specialised in immunology and oncology. She switched to clinical research in 2006 and worked several years in a global CRO focusing on international trials in oncology. Additional studies in Clinical Research and Regulatory Affairs complement her professional profile. Before she joined TILT in April 2018, she worked in a toxicological project at the European Chemicals Agency in Helsinki.